Senator Gary Peters (Mich.) is holding up a legislative proposal that would target U.S. adversaries’ biotech companies, including the Chinese-military-linked BGI Genomics, National Review has exclusively learned. His stance against the provision comes as the conglomerate wages a major lobbying offensive on Capitol Hill.
The DNA-sequencing giant, based in Shenzhen, has taken part in dystopian research projects focused on race and ethnicity in tandem with the People’s Liberation Army. The U.S. intelligence community has pointedly warned that BGI is part of a Chinese-government strategy to hoover up massive sets of genetic data from across the world.
Comments